Spojené státy - angličtina - NLM (National Library of Medicine)

putney, inc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime 100 mg - indications cefpodoxime proxetil tablets are indicated for the treatment of skin infections (wounds and abscesses) in dogs caused by susceptible strains of staphylococcus intermedius , staphylococcus aureus , streptococcus canis (group g, β hemolytic), escherichia coli, pasteurella multocida, and proteus mirabilis. contraindications cefpodoxime proxetil is contraindicated in dogs with known allergy to cefpodoxime or to the β-lactam (penicillins and cephalosporins) group of antibiotics.

Spojené státy - angličtina - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime 200 mg - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.  recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes , haemophilus influenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains).  pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note:  only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil

Spojené státy - angličtina - NLM (National Library of Medicine)

sandoz inc - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime 100 mg - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilus influenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note: only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. however, data establishing the efficacy of cefpodoxime proxetil for the pr

Spojené státy - angličtina - NLM (National Library of Medicine)

amici pharmaceuticals, llc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilusinfluenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note: only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. however, data establishing the efficacy of cefpodoxime pro

Spojené státy - angličtina - NLM (National Library of Medicine)

ascend laboratories, llc - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilusinfluenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note: only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. however, data establishing the efficacy of cefpodoxi

Spojené státy - angličtina - NLM (National Library of Medicine)

amici pharmaceuticals, llc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilusinfluenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note: only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. however, data establishing the efficacy of cefpodoxi

Spojené státy - angličtina - NLM (National Library of Medicine)

ascend laboratories, llc - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see  dosage and administration  for specific recommendations. acute otitis media  caused by streptococcus pneumoniae  (excluding penicillin-resistant strains), streptococcus pyogenes, haemophilusinfluenzae  (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis  (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis  caused by streptococcus pyogenes . note:  only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx. however, data establishing the efficacy of cefpodoxim

Spojené státy - angličtina - NLM (National Library of Medicine)

golden state medical supply, inc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see  dosage and administration  for specific recommendations. acute otitis media  caused by  streptococcus pneumoniae  (excluding penicillin-resistant strains),  streptococcus pyogenes, haemophilusinfluenzae  (including beta-lactamase-producing strains),  or moraxella (branhamella) catarrhalis  (including beta-lactamase-producing strains). pharyngitis and/or tonsillitis  caused by  streptococcus pyogenes . note:  only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil is generally effective in

Spojené státy - angličtina - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.  recommended dosages, durations of therapy, and applicable patient populations vary among these infections. please see dosage and administration for specific recommendations. acute otitis media caused by streptococcus pneumoniae (excluding penicillin-resistant strains), streptococcus pyogenes , haemophilus influenzae (including beta-lactamase-producing strains), or moraxella (branhamella) catarrhalis (including beta-lactamase-producing strains).  pharyngitis and/or tonsillitis caused by streptococcus pyogenes . note:  only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. cefpodoxime proxetil

Spojené státy - angličtina - NLM (National Library of Medicine)

zoetis inc. - cefpodoxime proxetil (unii: 2tb00a1z7n) (cefpodoxime - unii:7r4f94tvgy) - cefpodoxime 100 mg - cefpodoxime proxetil is contraindicated in dogs with known allergy to cefpodoxime or to the β-lactam (penicillins and cephalosporins) group of antibiotics.